Finch Therapeutics Group Inc (FNCH)
2.30
-0.19
(-7.63%)
USD |
NASDAQ |
May 03, 16:00
2.36
+0.06
(+2.61%)
After-Hours: 20:00
Finch Therapeutics Group Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | -59.76K% |
| December 31, 2022 | -337.6K% |
| September 30, 2022 | -29.25K% |
| June 30, 2022 | -6.29K% |
| March 31, 2022 | -6.94K% |
| December 31, 2021 | -2.36K% |
| September 30, 2021 | -87.76% |
| Date | Value |
|---|---|
| June 30, 2021 | -536.0% |
| March 31, 2021 | -393.5% |
| December 31, 2020 | -724.5% |
| September 30, 2020 | -569.7% |
| June 30, 2020 | -351.6% |
| March 31, 2020 | -440.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-337.6K%
Minimum
Dec 2022
-87.76%
Maximum
Sep 2021
-34.25K%
Average
-724.5%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 19.82% |
| Vanda Pharmaceuticals Inc | -5.30% |
| Sage Therapeutics Inc | -1.37K% |
| BioSig Technologies Inc | -50.41K% |
| Palisade Bio Inc | -- |